Treace Medical Concepts, Inc.
TMCI
$6.74
-$0.255-3.65%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 52.39% | 1.42% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 52.39% | 1.42% | |||
| Cost of Revenue | 47.77% | 1.97% | |||
| Gross Profit | 53.54% | 1.28% | |||
| SG&A Expenses | 9.00% | -10.78% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 14.35% | -8.53% | |||
| Operating Income | 99.00% | 29.22% | |||
| Income Before Tax | 96.74% | 27.57% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 96.74% | 27.57% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 96.74% | 27.57% | |||
| EBIT | 99.00% | 29.22% | |||
| EBITDA | 108.37% | 32.64% | |||
| EPS Basic | 96.76% | 27.75% | |||
| Normalized Basic EPS | 97.08% | 27.73% | |||
| EPS Diluted | 95.71% | 27.75% | |||
| Normalized Diluted EPS | 97.08% | 27.73% | |||
| Average Basic Shares Outstanding | 0.18% | 0.24% | |||
| Average Diluted Shares Outstanding | 0.18% | 0.24% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
